Clinical Reference: Brenipatide for Alcohol Use Disorder
In this seriesManuscript Summary5
About This Reference
This reference summarizes the recent findings on the efficacy and safety of brenipatide as a treatment for alcohol use disorder based on a randomized controlled trial.
What's Included
- Efficacy in maintaining abstinence: 68.1% in brenipatide vs. 39.8% in placebo.
- Significant reduction in craving severity scores in the treatment group.
- Improvement in quality of life measures among patients receiving brenipatide.
- Well-tolerated with a favorable safety profile.
📄
The full manuscript summary PDF will be available here shortly.
In the meantime, you can access the full article via the article hub.
This companion content was AI-assisted and reviewed by an editor. It does not constitute medical advice.